65100-24-5

Basic information

• Product Name: Propanedioic acid, bromo-, bis(phenylmethyl) ester
• CAS NO: 65100-24-5
• Molecular Formula: C17H15BrO4
• Molecular Weight: 363.208
• Mol File: 65100-24-5.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Propanedioic acid, bromo-, bis(phenylmethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanedioic acid, bromo-, bis(phenylmethyl) ester(65100-24-5)
• EPA Substance Registry System: Propanedioic acid, bromo-, bis(phenylmethyl) ester(65100-24-5)

Safety Data

• Hazardous Substances Data: 65100-24-5(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 100-51-6 benzyl alcohol 
• 15014-25-2 malonic acid dibenzyl ester 

Downstream Products

• 221077-07-2 dibenzyl 2-{4-[(2S)-2-[(tert-butoxycarbonyl)amino]-3-oxo-3-(pentylamino)propyl]phenoxy}malonate 
• 221077-13-0 dibenzyl 2-{4-[(2S)-2-{[4-(benzyloxy)-4-oxobutanoyl]amino}-3-(tert-butoxy)-3-oxopropyl]phenoxy}malonate 
• 221077-80-1 2-[4-(2-tert-butoxycarbonylamino-2-pentylcarbamoyl-ethyl)-2-fluoro-phenoxy]-malonic acid dibenzyl ester 
• 408537-95-1 4-oxo-1-phenyl-azetidine-2,2-dicarboxylic acid dibenzyl ester 
• 142890-18-4 (R)-2-[5-(tert-butyldiphenylsiloxy)methylpyrrolidin-2-ylidene]malonic acid dibenzyl ester 
• 142890-16-2 2-[(S)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-pyrrolidin-2-ylidene]-malonic acid dibenzyl ester 
• 1089672-00-3 dibenzyl 2-(4-methoxyphenyl)cyclopropane-1,1-dicarboxylate 

Relevant articles and documents

A Total Synthesis of Salinosporamide A

Salinosporamide A is a β-lactone proteasome inhibitor currently in clinical trials for the treatment of multiple-myeloma. Herein we report a short synthesis of this small, highly functionalized, biologically important natural product that uses an oxidative radical cyclization as a key step and allows for the preparation of gram quantities of advanced synthetic intermediates.

HETEROARYLS AND THEIR USE AS PI3K INHIBITORS

This invention provides compounds of formula (IA) or (IB): wherein R1, R2, G1 and HY are as described in the specification. The compounds are inhibitors of PI3K and/or mTor and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

INDOLE COMPOUNDS HAVING C4-ACIDIC SUBSTITUENTS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS

Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.